CRISPR Patent Process And Its Applicability In The Covid Era

INTRODUCTION

CRISPR technology is a targeted technique that allows researchers to modify genomes with unprecedented precision, efficiency, and flexibility. This technology is at the heart of a true biotechnology revolution, with huge implications for health, agriculture, and a variety of other sectors. On October 7, 2020, Professors Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in Chemistry by the Royal Swedish Academy of Sciences for their significant contributions to the CRISPR Cas9 gene-editing method.  One would imagine that when the idea's many applications are marketed around the world, the two award-winning scientists and the institutions to which they belong will reap the great economic rewards of their creation.However, behind the praises, a legal war over the intellectual property (IP) linked to the CRISPRCas9 technology has been raging for years.